Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 66.50%
March 31, 2026 66.42%
December 31, 2025 66.88%
September 30, 2025 67.10%
June 30, 2025 65.96%
March 31, 2025 66.57%
December 31, 2024 66.75%
September 30, 2024 66.50%
June 30, 2024 53.55%
March 31, 2024 64.11%
December 31, 2023 64.81%
September 30, 2023 64.67%
June 30, 2023 62.86%
March 31, 2023 61.55%
December 31, 2022 61.45%
September 30, 2022 62.17%
June 30, 2022 63.39%
March 31, 2022 61.52%
December 31, 2021 60.52%
September 30, 2021 62.96%
June 30, 2021 64.30%
March 31, 2021 65.68%
December 31, 2020 56.38%
September 30, 2020 60.05%
Date Value
June 30, 2020 61.59%
March 31, 2020 63.94%
December 31, 2019 67.42%
September 30, 2019 68.67%
June 30, 2019 69.84%
March 31, 2019 65.17%
December 31, 2018 65.00%
September 30, 2018 66.91%
June 30, 2018 65.71%
March 31, 2018 64.84%
December 31, 2017 66.24%
September 30, 2017 65.10%
June 30, 2017 63.32%
March 31, 2017 65.16%
December 31, 2016 63.72%
September 30, 2016 63.81%
June 30, 2016 63.70%
March 31, 2016 68.90%
December 31, 2015 67.00%
September 30, 2015 66.44%
June 30, 2015 64.70%
March 31, 2015 68.62%
June 30, 2014 65.76%
March 31, 2014 66.71%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Teleflex, Inc. 58.12%
Boston Scientific Corp. 66.50%
Globus Medical, Inc. 65.92%
Integra LifeSciences Holdings Corp. 54.87%
Abbott Laboratories 52.64%

Gross Profit Margin (Quarterly) Related Metrics